A single dose of pembrolizumab treatment causing a profound and durable response in lung cancer

Profound and durable responses to a single dose of pembrolizumab in lung cancer are rare. We encountered a non‐small cell lung cancer patient showing a deep and durable response with a single dose of pembrolizumab. A 79‐year‐old man reported bloody sputum for several weeks and visited a general phys...

Descripción completa

Detalles Bibliográficos
Autores principales: Kondo, Yoshihiro, Kunishige, Michihiro, Kadota, Naoki, Okano, Yoshio, Machida, Hisanori, Hatakeyama, Nobuo, Naruse, Keishi, Shinohara, Tsutomu, Takeuchi, Eiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841699/
https://www.ncbi.nlm.nih.gov/pubmed/35023292
http://dx.doi.org/10.1111/1759-7714.14314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841699/
https://www.ncbi.nlm.nih.gov/pubmed/35023292
http://dx.doi.org/10.1111/1759-7714.14314

Ejemplares similares